Evaluate the Levels of Serum Eotaxin-1, Myelin Basic Protein, and Some Immunological and Biochemical Markers in Iraqi Patients with Multiple Sclerosis

Abstract

     The central nervous system (CNS) disease known as multiple sclerosis (MS) is essentially an inflammatory demyelinating condition with a variety of clinical manifestations and variable histological findings. A number of immunological and biochemical markers may alter MS, which is also characterized as an autoimmune illness. MS patients (n = 100) were divided into two groups: newly diagnosed (n = 42) and patients with ongoing treatments (n = 58). These groups were compared to healthy subjects (n = 55); the mean age ±SD was (30±8.46 years), (37±8.06 years), and (31±8.73 years) for MS newly diagnosed patients, patients with ongoing treatments, and healthy subjects, respectively. Studies for serum levels of eotaxin-1, myelin basic protein (MBP), IL-23, 27, 9, and 37 were measured by the ELISA technique. Eotaxin-1, MBP, IL-23, 27, and alkaline phosphate were significantly higher in all MS patient groups, but for IL-37, there was no significant difference between newly diagnosed patients when compared with patients with ongoing treatment. Weak positive correlations were found between IL-9 and myelin (r = 0.282, p≤0.05) and a weak positive correlation between IL-23 and ALP (r = 0.209, p≤0.05) in MS patients. A receiver operating characteristic (ROC) curve analysis was applied for the parameters eotaxin-1, MBP, IL-23, 27, and alkaline phosphate, which showed a high sensitivity according to the area under the curve. The present results conclude that eotaxin-1, MBP, IL-23, 27, and alkaline phosphate can be used as diagnostic markers for multiple sclerosis.